Marchex (MCHX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Proxy statement filed for annual meeting, detailing matters for shareholder vote and governance disclosures.
Voting matters and shareholder proposals
Shareholders are asked to vote on key proposals, including director elections and other corporate actions.
Board of directors and corporate governance
Information provided on the board's composition and governance practices as required by SEC rules.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Marchex
- AI-driven product launches and the Archenia deal set the stage for accelerated growth in 2026.MCHX
Q4 202525 Mar 2026 - Net loss narrowed and adjusted EBITDA improved as revenue is set to grow in Q3.MCHXQ2 20242 Feb 2026
- Q3 2024 delivered $12.6M revenue, narrowed losses, and set the stage for AI-driven growth in 2025.MCHXQ3 202417 Jan 2026
- 2025 is set for sequential growth and margin improvement, driven by new AI products and partnerships.MCHXQ4 202424 Dec 2025
- Annual meeting to elect directors, ratify auditor, and highlight governance and compensation practices.MCHXProxy Filing1 Dec 2025
- Director elections, auditor ratification, and performance-based compensation highlight strong governance.MCHXProxy Filing1 Dec 2025
- Q1 2025 revenue $11.4M, net loss $2.0M, gross margin 63%, targeting $50M+ run rate.MCHXQ1 202525 Nov 2025
- Q2 2025 saw revenue dip 3% but net income and operational efficiency improved.MCHXQ2 202523 Nov 2025
- Q3 revenue fell, but profitability improved and Archenia acquisition aims for accelerated AI growth.MCHXQ3 202517 Nov 2025